Status:
COMPLETED
Metoclopramide Versus Placebo for GJ Placement
Lead Sponsor:
Duke University
Conditions:
Radiation Exposure
Enteral Nutrition
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The goal of this study is to determine whether use of promotility agents to stimulate gastric peristalsis can reduce fluoroscopy time and procedure time during gastrojejunostomy (GJ) tubes placement i...
Detailed Description
Gastrojejunostomy tube placement is a commonly performed procedure for providing nutritional support in patients unable to tolerate gastric feeds due to gastric outlet or duodenal obstruction or sever...
Eligibility Criteria
Inclusion
- 18 years old or older
- undergoing de novo GJ placement as part of their routine clinical care
Exclusion
- Patient pregnant
- Contraindications to metoclopramide including:
- allergic reaction
- pheochromocytoma
- QTc prolongation
- history of seizure disorder
- extrapyramidal symptoms
Key Trial Info
Start Date :
April 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 3 2019
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03331965
Start Date
April 9 2018
End Date
October 3 2019
Last Update
July 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Hospital
Durham, North Carolina, United States, 27710